Health Care | Health Care Equipment & Services | Health Care Equipment & Supplies | Health Care Equipment
NASDAQ | Common Stock
Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina.
Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data.
The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area.
In addition, the company licenses its proprietary hosted technology platform to various life science institutions.
It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies.
Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
As of March 11, 2024, Science 37 Holdings, Inc. operates as a subsidiary of eMed, LLC.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 7, 23 | -0.04 Increased by +76.47% | -0.07 Increased by +42.86% |
| Aug 8, 23 | -0.07 Increased by +58.82% | -0.12 Increased by +41.67% |
| May 15, 23 | -0.11 Increased by +38.89% | -0.13 Increased by +15.38% |
| Mar 6, 23 | -0.14 Increased by +36.36% | -0.18 Increased by +22.22% |
| Nov 10, 22 | -0.17 Increased by +94.44% | -0.18 Increased by +5.56% |
| Aug 11, 22 | -0.17 Increased by +90.66% | -0.20 Increased by +15.00% |
| May 9, 22 | -0.18 Decreased by -1.70 K% | -0.22 Increased by +18.18% |
| Mar 22, 22 | -0.22 Decreased by -2.10 K% | -0.21 Decreased by -4.76% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 14.89 M Decreased by -8.38% | -13.92 M Increased by +30.50% | Decreased by -93.53% Increased by +24.14% |
| Jun 30, 23 | 15.35 M Decreased by -20.36% | -19.58 M Decreased by -153.92% | Decreased by -127.54% Decreased by -167.71% |
| Mar 31, 23 | 14.09 M Decreased by -24.62% | -23.51 M Decreased by -152.36% | Decreased by -166.89% Decreased by -169.46% |
| Dec 31, 22 | 15.94 M Decreased by -21.79% | -66.52 M Decreased by -2.18% | Decreased by -417.43% Decreased by -30.65% |
| Sep 30, 22 | 16.25 M Increased by +N/A% | -20.03 M Decreased by -2.31 K% | Decreased by -123.29% Decreased by N/A% |
| Jun 30, 22 | 19.27 M Increased by +N/A% | 36.31 M Increased by +N/A% | Increased by +188.37% - |
| Mar 31, 22 | 18.69 M Increased by +50.23% | 44.89 M Increased by +757.69% | Increased by +240.25% Increased by +537.78% |
| Dec 31, 21 | 20.38 M Increased by +N/A% | -65.10 M Decreased by -80.73 K% | Decreased by -319.49% - |